{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:01:19Z","timestamp":1793037679492,"version":"4.5.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["World Neurosurgery"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.wneu.2022.06.020","type":"journal-article","created":{"date-parts":[[2022,6,10]],"date-time":"2022-06-10T15:43:49Z","timestamp":1654875829000},"page":"e251-e264","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["H3K27M-Altered Diffuse Midline Gliomas Among Adult Patients: A Systematic Review of Clinical Features and Survival Analysis"],"prefix":"10.1016","volume":"165","author":[{"given":"Othman","family":"Bin-Alamer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0631-5981","authenticated-orcid":false,"given":"Adrian E.","family":"Jimenez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tej D.","family":"Azad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9991-7123","authenticated-orcid":false,"given":"Chetan","family":"Bettegowda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5403-8237","authenticated-orcid":false,"given":"Debraj","family":"Mukherjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.wneu.2022.06.020_bib1","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.soncn.2018.10.001","article-title":"Epidemiology and Overview of Gliomas","volume":"34","author":"Davis","year":"2018","journal-title":"Semin Oncol Nurs"},{"key":"10.1016\/j.wneu.2022.06.020_bib2","doi-asserted-by":"crossref","first-page":"8368","DOI":"10.1038\/s41598-020-65272-x","article-title":"Histone H3K27M mutation overrides histological grading in pediatric gliomas","volume":"10","author":"Mosaab","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.wneu.2022.06.020_bib3","doi-asserted-by":"crossref","first-page":"136","DOI":"10.2176\/nmc.oa.2019-0168","article-title":"Midline glioma in adults: clinicopathological, genetic, and epigenetic analysis","volume":"60","author":"Enomoto","year":"2020","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"10.1016\/j.wneu.2022.06.020_bib4","doi-asserted-by":"crossref","first-page":"153483","DOI":"10.1016\/j.prp.2021.153483","article-title":"Simplified approach for pathological diagnosis of diffuse gliomas in adult patients","volume":"223","author":"Santisukwongchote","year":"2021","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.wneu.2022.06.020_bib5","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.5858\/arpa.2017-0249-RA","article-title":"Pediatric thalamic gliomas an updated review","volume":"141","author":"Gupta","year":"2017","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.wneu.2022.06.020_bib6","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/neuonc\/nox149","article-title":"Diffuse high-grade gliomas with H3 K27M mutations carry a dismal prognosis independent of tumor location","volume":"20","author":"Karremann","year":"2018","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.wneu.2022.06.020_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.14791\/btrt.2021.9.e8","article-title":"The Korean Society for Neuro-Oncology (KSNO) guideline for adult diffuse Midline Glioma: Version 2021.1","volume":"9","author":"Yoon","year":"2021","journal-title":"Brain Tumor Res Treat"},{"key":"10.1016\/j.wneu.2022.06.020_bib8","doi-asserted-by":"crossref","first-page":"795","DOI":"10.3174\/ajnr.A5076","article-title":"Imaging characteristics of pediatric diffuse midline gliomas with histone H3 K27M mutation","volume":"38","author":"Aboian","year":"2017","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.wneu.2022.06.020_bib9","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/s41571-020-00447-z","article-title":"EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood","volume":"18","author":"Weller","year":"2021","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.wneu.2022.06.020_bib10","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3389\/fonc.2019.00031","article-title":"Treatment strategies in diffuse midline gliomas with the H3K27M mutation: the role of convection-enhanced delivery in overcoming anatomic challenges","volume":"9","author":"Himes","year":"2019","journal-title":"Front Oncol"},{"key":"10.1016\/j.wneu.2022.06.020_bib11","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1093\/neuonc\/now274","article-title":"Characteristics of H3 K27M-mutant gliomas in adults","volume":"19","author":"Meyronet","year":"2017","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.wneu.2022.06.020_bib12","first-page":"vdab038","article-title":"H3K27M and TERT promoter mutations are poor prognostic factors in surgical cases of adult thalamic high-grade glioma","volume":"3","author":"Osada","year":"2021","journal-title":"Neurooncol Adv"},{"key":"10.1016\/j.wneu.2022.06.020_bib13","doi-asserted-by":"crossref","first-page":"389","DOI":"10.4143\/crt.2020.694","article-title":"Clinical and genomic characteristics of adult diffuse midline glioma","volume":"53","author":"Park","year":"2021","journal-title":"Cancer Res Treat"},{"key":"10.1016\/j.wneu.2022.06.020_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jocn.2020.10.005","article-title":"Adult diffuse midline gliomas: clinical, radiological, and genetic characteristics","volume":"82","author":"Dono","year":"2020","journal-title":"J\u00a0Clin Neurosci"},{"key":"10.1016\/j.wneu.2022.06.020_bib15","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1093\/jnen\/nly006","article-title":"Adult brainstem gliomas with H3K27M mutation: radiology, pathology, and prognosis","volume":"77","author":"Daoud","year":"2018","journal-title":"J\u00a0Neuropathol Exp Neurol"},{"key":"10.1016\/j.wneu.2022.06.020_bib16","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.wneu.2022.06.020_bib17","series-title":"Manual for Evidence Synthesis","article-title":"Chapter 7: systematic reviews of etiology and risk","author":"Moola","year":"2020"},{"key":"10.1016\/j.wneu.2022.06.020_bib18","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s10014-017-0288-6","article-title":"Histone H3 K27M mutations in adult cerebellar high-grade gliomas","volume":"34","author":"Nakata","year":"2017","journal-title":"Brain Tumor Pathol"},{"key":"10.1016\/j.wneu.2022.06.020_bib19","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1007\/s00401-017-1780-0","article-title":"Diffuse midline gliomas with subclonal H3F3A K27M mutation and mosaic H3.3 K27M mutant protein expression","volume":"134","author":"Lopez","year":"2017","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.wneu.2022.06.020_bib20","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/neuonc\/not144","article-title":"H3F3A K27M mutations in thalamic gliomas from young adult patients","volume":"16","author":"Aihara","year":"2014","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.wneu.2022.06.020_bib21","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s10014-017-0305-9","article-title":"A\u00a0case report of adult cerebellar high-grade glioma with H3.1 K27M mutation: a rare example of an H3 K27M mutant cerebellar tumor","volume":"35","author":"Funata","year":"2018","journal-title":"Brain Tumor Pathol"},{"key":"10.1016\/j.wneu.2022.06.020_bib22","first-page":"293","article-title":"An atypical presentation of diffuse midline pontine glioma in a middle age patient: case report","volume":"71","author":"Floro","year":"2020","journal-title":"J\u00a0Clin Neurosci Off J Neurosurg Soc Australas"},{"key":"10.1016\/j.wneu.2022.06.020_bib23","first-page":"vdaa156","article-title":"Bone metastases in an adult patient with diffuse midline glioma: a case report","volume":"3","author":"Li","year":"2021","journal-title":"Neurooncol Adv"},{"key":"10.1016\/j.wneu.2022.06.020_bib24","first-page":"144","article-title":"H3K27M-mutant diffuse midline glioma presenting as synchronous lesions involving pineal and suprasellar region: a case report and literature review","volume":"81","author":"Lim","year":"2020","journal-title":"J\u00a0Clin Neurosci Off J Neurosurg Soc Australas"},{"key":"10.1016\/j.wneu.2022.06.020_bib25","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.wneu.2020.02.134","article-title":"Diffuse midline gliomas without the H3 K27M mutation: surgical biopsy is needed to better our diagnostic understanding","volume":"137","author":"Lu","year":"2020","journal-title":"World Neurosurg"},{"key":"10.1016\/j.wneu.2022.06.020_bib26","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.wneu.2019.04.054","article-title":"Slow-growing thalamic glioma with histone H3 Lysine 27-to-methionine mutation: 3-year follow-up before surgical intervention","volume":"127","author":"Chanchotisatien","year":"2019","journal-title":"World Neurosurg"},{"key":"10.1016\/j.wneu.2022.06.020_bib27","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/neup.12609","article-title":"A\u00a0case of diffuse midline glioma, H3 K27M mutant mimicking a hemispheric malignant glioma in an elderly patient","volume":"40","author":"Fujioka","year":"2020","journal-title":"Neuropathology"},{"key":"10.1016\/j.wneu.2022.06.020_bib28","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.wneu.2019.04.172","article-title":"A\u00a0rare high-grade glioma with a histone H3 K27M mutation in the Hypothalamus of an adult patient","volume":"128","author":"He","year":"2019","journal-title":"World Neurosurg"},{"key":"10.1016\/j.wneu.2022.06.020_bib29","doi-asserted-by":"crossref","first-page":"CNS71","DOI":"10.2217\/cns-2020-0030","article-title":"Diffuse midline glioma with H3 K27M-mutation in an 83-year-old woman","volume":"10","author":"Low","year":"2021","journal-title":"CNS Oncol"},{"key":"10.1016\/j.wneu.2022.06.020_bib30","first-page":"2579","article-title":"H3K27M mutant diffuse midline glioma: a case report","volume":"24","author":"Luo","year":"2020","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.wneu.2022.06.020_bib31","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s11060-019-03134-x","article-title":"Incidence and clinicopathologic features of H3 K27M mutations in adults with radiographically-determined midline gliomas","volume":"143","author":"Schreck","year":"2019","journal-title":"J\u00a0Neurooncol"},{"key":"10.1016\/j.wneu.2022.06.020_bib32","doi-asserted-by":"crossref","first-page":"105888","DOI":"10.1016\/j.clineuro.2020.105888","article-title":"Long term follow-up and outcomes in adult patients with thalamic gliomas","volume":"195","author":"Li","year":"2020","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.wneu.2022.06.020_bib33","doi-asserted-by":"crossref","first-page":"e1169","DOI":"10.1016\/j.wneu.2019.03.061","article-title":"Clinical and molecular characteristics of thalamic gliomas: retrospective report of 26 cases","volume":"126","author":"Liu","year":"2019","journal-title":"World Neurosurg"},{"key":"10.1016\/j.wneu.2022.06.020_bib34","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s00401-015-1454-8","article-title":"Adult IDH wild type astrocytomas biologically and clinically resolve into other tumor entities","volume":"130","author":"Reuss","year":"2015","journal-title":"Acta Neuropathol"},{"issue":"Supplement_1","key":"10.1016\/j.wneu.2022.06.020_bib35","doi-asserted-by":"crossref","first-page":"IV1","DOI":"10.1093\/neuonc\/noaa200","article-title":"CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2013-2017","volume":"22","author":"Ostrom","year":"2020","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.wneu.2022.06.020_bib36","doi-asserted-by":"crossref","first-page":"308","DOI":"10.3171\/2018.9.PEDS18419","article-title":"Impact of the H3K27M mutation on survival in pediatric high-grade glioma: a systematic review and meta-analysis","volume":"23","author":"Lu","year":"2018","journal-title":"J\u00a0Neurosurg Pediatr"},{"key":"10.1016\/j.wneu.2022.06.020_bib37","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/bpa.12336","article-title":"Diffuse midline gliomas with histone H3-K27M mutation: a series of 47 cases assessing the spectrum of morphologic variation and associated genetic alterations","volume":"26","author":"Solomon","year":"2016","journal-title":"Brain Pathol"},{"key":"10.1016\/j.wneu.2022.06.020_bib38","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.2214\/ajr.165.5.7572512","article-title":"Intracranial subependymomas: CT and MR imaging features in 24 cases","volume":"165","author":"Chiechi","year":"1995","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.wneu.2022.06.020_bib39","first-page":"5758","article-title":"Pineal region tumors: pathophysiological mechanisms of presenting symptoms","volume":"13","author":"Mavridis","year":"2021","journal-title":"Am J Transl Res"},{"key":"10.1016\/j.wneu.2022.06.020_bib40","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s00401-014-1319-6","article-title":"Histopathological spectrum of paediatric diffuse intrinsic pontine glioma: diagnostic and therapeutic implications","volume":"128","author":"Buczkowicz","year":"2014","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.wneu.2022.06.020_bib41","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s11060-014-1702-0","article-title":"Temozolomide and pasireotide treatment for aggressive pituitary adenoma: expertise at a tertiary care center","volume":"122","author":"Ceccato","year":"2015","journal-title":"J\u00a0Neurooncol"},{"key":"10.1016\/j.wneu.2022.06.020_bib42","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1007\/s00401-017-1690-1","article-title":"Adult infiltrating gliomas with WHO 2016 integrated diagnosis: additional prognostic roles of ATRX and TERT","volume":"133","author":"Pekmezci","year":"2017","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.wneu.2022.06.020_bib43","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s00401-013-1156-z","article-title":"ATRX loss refines the classification of anaplastic gliomas and identifies a subgroup of IDH mutant astrocytic tumors with better prognosis","volume":"126","author":"Wiestler","year":"2013","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.wneu.2022.06.020_bib44","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s00401-012-1031-3","article-title":"Frequent ATRX mutations and loss of expression in adult diffuse astrocytic tumors carrying IDH1\/IDH2 and TP53 mutations","volume":"124","author":"Liu","year":"2012","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.wneu.2022.06.020_bib45","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/NEN.0000000000000167","article-title":"Molecular classification defines 4 prognostically distinct glioma groups irrespective of diagnosis and grade","volume":"74","author":"Mur","year":"2015","journal-title":"J\u00a0Neuropathol Exp Neurol"},{"key":"10.1016\/j.wneu.2022.06.020_bib46","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.humpath.2018.04.015","article-title":"H3 K27M\u2013mutant diffuse midline gliomas in different anatomical locations","volume":"78","author":"Wang","year":"2018","journal-title":"Hum Pathol"},{"key":"10.1016\/j.wneu.2022.06.020_bib47","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/pbc.21154","article-title":"Treatment of children with diffuse intrinsic brain stem glioma with radiotherapy, vincristine and oral VP-16: a Children\u2019s Oncology Group phase II study","volume":"50","author":"Korones","year":"2008","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.wneu.2022.06.020_bib48","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1093\/neuonc\/5.1.8","article-title":"A\u00a0phase I study of topotecan as a radiosensitizer for brainstem glioma of childhood: first report of the Children\u2019s Cancer Group-0952","volume":"5","author":"Sanghavi","year":"2003","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.wneu.2022.06.020_bib49","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0360-3016(93)90228-N","article-title":"Final results of a study of escalating doses of hyperfractionated radiotherapy in brain stem tumors in children: a Pediatric Oncology Group study","volume":"27","author":"Freeman","year":"1993","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.wneu.2022.06.020_bib50","doi-asserted-by":"crossref","first-page":"3431","DOI":"10.1200\/JCO.2002.04.109","article-title":"Preradiation chemotherapy in primary high-risk brainstem tumors: phase II study CCG-9941 of the Children\u2019s Cancer Group","volume":"20","author":"Jennings","year":"2002","journal-title":"J\u00a0Clin Oncol Off J Am Soc Clin Oncol"},{"key":"10.1016\/j.wneu.2022.06.020_bib51","first-page":"227","article-title":"Brain-stem tumors in childhood: a prospective randomized trial of irradiation with and without adjuvant CCNU, VCR, and prednisone. A report of the Childrens Cancer Study Group","volume":"66","author":"Jenkin","year":"1987","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.wneu.2022.06.020_bib52","doi-asserted-by":"crossref","first-page":"290","DOI":"10.2176\/nmc.ra.2018-0044","article-title":"MGMT expression contributes to temozolomide resistance in H3K27M-Mutant diffuse midline gliomas and MGMT silencing to temozolomide sensitivity in IDH-mutant gliomas","volume":"58","author":"Abe","year":"2018","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"10.1016\/j.wneu.2022.06.020_bib53","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s40478-020-00913-w","article-title":"The molecular characteristics of spinal cord gliomas with or without H3 K27M mutation","volume":"8","author":"Chai","year":"2020","journal-title":"Acta Neuropathol Commun"},{"key":"10.1016\/j.wneu.2022.06.020_bib54","doi-asserted-by":"crossref","first-page":"290","DOI":"10.3389\/fonc.2019.01568","article-title":"MGMT expression contributes to temozolomide resistance in H3K27M-mutant diffuse midline gliomas","volume":"9","author":"Abe","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.wneu.2022.06.020_bib55","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.ccr.2013.10.006","article-title":"Reduced H3K27me3 and DNA hypomethylation are major drivers of gene expression in K27M mutant pediatric high-grade gliomas","volume":"24","author":"Bender","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1016\/j.wneu.2022.06.020_bib56","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S1470-2045(06)70615-5","article-title":"Diffuse brainstem glioma in children: critical review of clinical trials","volume":"7","author":"Hargrave","year":"2006","journal-title":"Lancet Oncol"}],"container-title":["World Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878875022008038?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878875022008038?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T09:08:33Z","timestamp":1761815313000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878875022008038"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":56,"alternative-id":["S1878875022008038"],"URL":"https:\/\/doi.org\/10.1016\/j.wneu.2022.06.020","relation":{},"ISSN":["1878-8750"],"issn-type":[{"value":"1878-8750","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"H3K27M-Altered Diffuse Midline Gliomas Among Adult Patients: A Systematic Review of Clinical Features and Survival Analysis","name":"articletitle","label":"Article Title"},{"value":"World Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.wneu.2022.06.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}